Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Fulvestrant MeSH Descriptor Data 2025


MeSH Heading
Fulvestrant
Tree Number(s)
D04.210.500.365.415.248.660
D06.472.334.851.437.500.500
Unique ID
D000077267
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000077267
Scope Note
An estradiol derivative and estrogen receptor antagonist that is used for the treatment of estrogen receptor-positive, locally advanced or metastatic breast cancer.
Entry Term(s)
7-(9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)estra-1,3,5(10)-triene-3,17-diol
Faslodex
ICI 182,780
ICI 182780
ICI-182780
ZM 182780
ZM-182780
Pharm Action
Antineoplastic Agents, Hormonal
Estrogen Receptor Antagonists
Registry Numbers
22X328QOC4
0
Related Numbers
129453-61-8
Public MeSH Note
2019; FULVESTRANT was indexed under ESTRADIOL/analogs & derivatives 1991-2019
History Note
2019 (1991)
Date Established
2019/01/01
Date of Entry
2018/07/09
Revision Date
2018/06/19
Fulvestrant Preferred
ICI 182780 Narrower
Faslodex Narrower
ZM 182780 Narrower
page delivered in 0.122s